Key result
Adrenomedullin ameliorates hypoxia-induced epithelial-to-mesenchymal transition in renal tubular cells by inhibiting ERK activation.
Why the study?
The mechanisms underlying the involvement of epithelial-to-mesenchymal transition in renal fibrosis remain to be elucidated, including the role of adrenomedullin under hypoxia.
Does adrenomedullin ameliorate hypoxia-induced epithelial-to-mesenchymal transition in human proximal tubular epithelial cells?
Does adrenomedullin ameliorate hypoxia-induced epithelial-to-mesenchymal transition in human proximal tubular epithelial cells?
Adrenomedullin suppresses hypoxia-induced epithelial-to-mesenchymal transition in human proximal tubular epithelial cells by inhibiting ERK activation, suggesting a potential therapeutic target for renal fibrosis.
Hypothesis-generating for adrenomedullin in renal fibrosis; does not support clinical translation from cell-level data.
Renal tubular epithelial cells can enter the epithelial‑to‑mesenchymal transition (EMT) in response to chronic hypoxia. EMT is a process which involves the phenotypic conversion of epithelial cells, that is believed to have an important role in renal fibrosis. However, the underlying mechanisms of the involvement of EMT in renal fibrosis remain to be elucidated. Adrenomedullin (AMD) has been implicated in renal fibrosis and is induced by hypoxia. The aims of the present study were to determine whether ADM signaling was active in human proximal tubular epithelial cells cultured under hypoxic conditions, and to observe the activity of ADM during EMT. The expression levels of ADM were significantly increased, in a time‑dependent manner, in HK‑2 and HKC human proximal tubular epithelial cells, cultured under hypoxic conditions. Overexpression of exogenous ADM was accompanied by increased expression levels of the epithelial markers E‑cadherin and tight junction protein‑1, and decreased expression levels of the mesenchymal markers vimentin and α‑smooth muscle actin, during hypoxia. Knock‑down of ADM expression by small hairpin RNA, or co‑administration of an ADM peptide inhibitor, in HK‑2 cells significantly exacerbated hypoxia‑induced EMT, as compared to the lack of effect observed in the untransfected controls. ADM was shown to suppress EMT by inhibiting the activation of extracellular signal‑regulated kinase (ERK), and this effect was prevented by the ERK activator apigenin. The results of the present study suggest that ADM has an important role in promoting EMT in hypoxic human proximal tubular epithelial cells. ADM may therefore represent a novel therapeutic target in the treatment of injured kidneys.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2015) studied Renal fibrosis and epithelial-to-mesenchymal transition. Adrenomedullin (ADM) vs. Control (no ADM) or ADM peptide inhibitor was evaluated on Expression levels of epithelial and mesenchymal markers (e.g., E-cadherin, vimentin) (p=<0.0001). Exogenous adrenomedullin significantly ameliorated hypoxia-induced epithelial-to-mesenchymal transition in human proximal tubular epithelial cells by inhibiting ERK activation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: